These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16842163)

  • 1. Angiogenesis as a therapeutic target in arthritis: lessons from oncology.
    Bainbridge J; Sivakumar B; Paleolog E
    Curr Pharm Des; 2006; 12(21):2631-44. PubMed ID: 16842163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience.
    Thairu N; Kiriakidis S; Dawson P; Paleolog E
    Angiogenesis; 2011 Sep; 14(3):223-34. PubMed ID: 21431303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood vessels, a potential therapeutic target in rheumatoid arthritis?
    Semerano L; Clavel G; Assier E; Denys A; Boissier MC
    Joint Bone Spine; 2011 Mar; 78(2):118-23. PubMed ID: 20851025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripterygium wilfordii Inhibiting Angiogenesis for Rheumatoid Arthritis Treatment.
    Zhang W; Li F; Gao W
    J Natl Med Assoc; 2017 Summer; 109(2):142-148. PubMed ID: 28599756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of angiogenesis: ready for prime time?
    Maracle CX; Tas SW
    Best Pract Res Clin Rheumatol; 2014 Aug; 28(4):637-49. PubMed ID: 25481555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis inhibitors for the treatment of chronic autoimmune inflammatory arthritis.
    Schoettler N; Brahn E
    Curr Opin Investig Drugs; 2009 May; 10(5):425-33. PubMed ID: 19431075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis in rheumatoid arthritis.
    Paleolog EM
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S81-90. PubMed ID: 12110126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vasculature in rheumatoid arthritis: cause or consequence?
    Paleolog EM
    Int J Exp Pathol; 2009 Jun; 90(3):249-61. PubMed ID: 19563609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance.
    Szekanecz Z; Szegedi G; Koch AE
    J Investig Med; 1998 Feb; 46(2):27-41. PubMed ID: 9549225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis as a potential treatment strategy for rheumatoid arthritis.
    Wang Y; Wu H; Deng R
    Eur J Pharmacol; 2021 Nov; 910():174500. PubMed ID: 34509462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in rheumatoid arthritis.
    Szekanecz Z; Gáspár L; Koch AE
    Front Biosci; 2005 May; 10():1739-53. PubMed ID: 15769663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis and vasculogenesis in rheumatoid arthritis.
    Szekanecz Z; Besenyei T; Szentpétery A; Koch AE
    Curr Opin Rheumatol; 2010 May; 22(3):299-306. PubMed ID: 20305562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting.
    Veale DJ; Fearon U
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):941-7. PubMed ID: 16980216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting synovial neoangiogenesis in rheumatoid arthritis.
    Leblond A; Allanore Y; Avouac J
    Autoimmun Rev; 2017 Jun; 16(6):594-601. PubMed ID: 28414154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis as a therapeutic target in arthritis: learning the lessons of the colorectal cancer experience.
    Khong TL; Larsen H; Raatz Y; Paleolog E
    Angiogenesis; 2007; 10(4):243-58. PubMed ID: 17805984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy.
    D'Onofrio A; Gandolfi A
    Math Med Biol; 2009 Mar; 26(1):63-95. PubMed ID: 19033598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of angiogenic factors in rheumatoid arthritis.
    Azizi G; Boghozian R; Mirshafiey A
    Int J Rheum Dis; 2014 May; 17(4):369-83. PubMed ID: 24467605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models.
    Lee JD; Huh JE; Jeon G; Yang HR; Woo HS; Choi DY; Park DS
    Int Immunopharmacol; 2009 Mar; 9(3):268-76. PubMed ID: 19111632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis as a target in rheumatoid arthritis.
    Koch AE
    Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii60-7. PubMed ID: 14532152
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.